{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/266590530"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "In addition, OTPs who are fully compliant with the protocol of an investigational use of a drug and other conditions set forth in the application may administer a drug that has been authorized by the Food and Drug Administration under an investigational new drug application under section 505(i) of the Federal Food, Drug, and Cosmetic Act for investigational use in the treatment of opioid addiction" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "cornell.edu" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/262271912"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/266590530"] } } }
